Home>News> Mylan, which bought Novartis CF drugs, circles back for the manufacturing assets

Mylan, which bought Novartis CF drugs, circles back for the manufacturing assets

Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them.
 
Mylan took an option on a Novartis plant in San Carlos, California, when it shelled out $463 million last year for Novartis’ TOBI Podhaler and TOBI liquid. It exercised the option in May for the plant “required to manufacture” the products, a Novartis spokesman said in an email today.

Tags: